Clinical Trial Update: E-cigarette Harm Reduction Among PLWHA in South Africa [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating e-cigarette harm reduction among people living with HIV/AIDS in South Africa; currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Tobacco Use Disorder

Snippet

Sponsor: NYU Langone Health | Conditions: Tobacco Smoking | Phase 1 | Status: ACTIVE_NOT_RECRUITING